Gerresheimer AG (ETR:GXI)
Market Cap | 1.85B |
Revenue (ttm) | 2.09B |
Net Income (ttm) | 78.70M |
Shares Out | 34.54M |
EPS (ttm) | 2.28 |
PE Ratio | 23.52 |
Forward PE | 10.03 |
Dividend | 1.25 (2.34%) |
Ex-Dividend Date | Jun 6, 2025 |
Volume | 285,266 |
Average Volume | 317,544 |
Open | 53.60 |
Previous Close | 53.40 |
Day's Range | 51.90 - 54.00 |
52-Week Range | 49.56 - 109.70 |
Beta | 0.95 |
RSI | 30.52 |
Earnings Date | Apr 11, 2025 |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufactu... [Read more]
Financial Performance
In 2024, Gerresheimer AG's revenue was 2.04 billion, an increase of 2.28% compared to the previous year's 1.99 billion. Earnings were 109.72 million, a decrease of -5.52%.
Financial StatementsNews

EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributi...
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Organic Challenges
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Organic Challenges
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Transcript
Gerresheimer Non-GAAP EPS of Є0.46, revenue of Є520.1M; initiates FY25 outlook

Gerresheimer's first-quarter results hit by low demand in moulded glass
German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe reve...

Bormioli Pharma Boosts Gerresheimer's Revenue & Earnings Growth
Gerresheimer's Q1 2025 financial performance paints a picture of strategic growth amidst market challenges, driven by key acquisitions and poised for future expansion. Jetzt den vollständigen Artikel ...

EQS-News: Gerresheimer: Bormioli Pharma boosts revenues and earnings
EQS-News: Gerresheimer AG / Key word(s): Quarterly / Interim Statement Gerresheimer: Bormioli Pharma boosts revenues and earnings 11.04.2025 / 07:00 CET/CEST The issuer is solely responsible for the c...

KKR drops out of consortium seeking Gerresheimer takeover, Bloomberg News reports
KKR has abandoned a private equity consortium discussing a takeover of Gerresheimer AG , Bloomberg News reported on Thursday, citing people familiar with the matter.

Exclusive: KKR, Warburg Pincus group submitted non-binding bid for Gerresheimer, sources say
A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG , which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the matt...

Warburg Pincus, KKR in Advanced Talks to Buy Gerresheimer
A consortium consisting of Warburg Pincus and KKR & Co. are in talks to acquire Gerresheimer AG, the German maker of packaging for drugs and cosmetics.
KKR, Warburg Picus in talks to acquire Gerresheimer - Bloomberg

Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports
A consortium consisting of Warburg Pincus and KKR are in talks to acquire German medical packaging maker Gerresheimer AG , Bloomberg News reported on Wednesday citing people familiar with the matter.
Gerresheimer AG (GRRMY) Q4 2024 Earnings Call Highlights: Strong Q4 Performance Amid Strategic ...
Gerresheimer AG (GRRMY) Q4 2024 Earnings Call Highlights: Strong Q4 Performance Amid Strategic Shifts
Gerresheimer AG (GRRMF) Q4 2024 Earnings Call Transcript
Gerresheimer AG reports Q4 results

Gerresheimer slashes revenue guidance for 2025 in half
German packaging and medical equipment maker Gerresheimer halved its guidance for 2025 on Wednesday.

Gerresheimer Thrives in 2024: Solid Results Amid Market Challenges
In 2024, Gerresheimer showcased resilience with notable financial achievements and promising future prospects, despite market hurdles. Jetzt den vollständigen Artikel lesen

EQS-News: Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
EQS-News: Gerresheimer AG / Key word(s): Annual Results Gerresheimer delivers solid results in the financial year 2024 despite market headwinds 26.02.2025 / 07:00 CET/CEST The issuer is solely respons...

Gerresheimer draws interest from Phillips-Medisize and Bain, Bloomberg News reports
German medical packaging maker Gerresheimer has garnered interest from US medical solutions company Phillips-Medisize and buyout firm Bain Capital for parts or all of Gerresheimer, Bloomberg News repo...

EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Tender Offer Gerresheimer AG confirms discussions with private equity investors on potential takeover offer 07-Feb-2025 / 16:26 CET/CEST Disclosure of an ins...

German packaging firm Gerresheimer exploring sale, Bloomberg News reports
German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter.

Gerresheimer: FDA grants Tentative Approval of SQ Innovation's Lasix® ONYU* (FOTO)
Düsseldorf (ots) - - Innovative combination product of furosemide and on-body device - Ready-to-market device designed, developed and manufactured by Gerresheimer - Patented device technology for prec...

EQS-News: Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU*
EQS-News: Gerresheimer AG / Key word(s): Miscellaneous/Regulatory Admission Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU* 16.12.2024 / 09:00 CET/CEST The issuer is solely ...

Gerresheimer Seals Deal: Acquires Bormioli Pharma's Holding Company
Gerresheimer AG has bolstered its market presence by acquiring Blitz LuxCo Sarl, the parent of Bormioli Pharma Group, enhancing its European production and product offerings in the pharma and biotech ...

EQS-News: Gerresheimer builds new production capacities for glass syringes at Skopje site
EQS-News: Gerresheimer AG / Key word(s): Expansion Gerresheimer builds new production capacities for glass syringes at Skopje site 02.12.2024 / 13:30 CET/CEST The issuer is solely responsible for the ...